Human leukocyte antigen B58 supertype and human immunodeficiency virus type 1 infection in native Africans

Journal of Virology

Volumn 80, Issue 12, 2006, Pages 6056-6060

  Lazaryan, Aleksandr ^a   Lobashevsky, Elena ^a   Mulenga, Joseph ^d   Karita, Etienne ^e   Allen, Susan ^f   Tang, Jianming ^b   Kaslow, Richard A ^a,b,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d Zambia Blood Transfusion Service   (Zambia)

^e Project San Francisco   (Rwanda)

^f EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HLA B58 ANTIGEN; HLA C ANTIGEN; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ARTICLE; DISEASE COURSE; FEMALE; HAPLOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RWANDA; VIRUS LOAD; ZAMBIA;

AFRICA; AFRICAN CONTINENTAL ANCESTRY GROUP; DISEASE SUSCEPTIBILITY; HAPLOTYPES; HIV INFECTIONS; HIV-1; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; RWANDA; ZAMBIA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33744930848     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02119-05     Document Type: Article

References (32)

1. Altfeld, M., M. M. Addo, E. S. Rosenberg, F. M. Hecht, P. K. Lee, M. Vogel, X. G. Yu, R. Draenert, M. N. Johnston, D. Strick, T. M. Allen, M. E. Feeney, J. O. Kahn, R. P. Sekaly, J. A. Levy, J. K. Rockstroh, P. J. Goulder, and B. D. Walker. 2003. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS 17:2581-2591.
2. Barber, L. D., L. Percival, K. L. Arnett, J. E. Gumperz, L. Chen, and P. Parham. 1997. Polymorphism in the alpha 1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity. J. Immunol. 158:1660-1669.
3. Bello, G., C. Casado, V. Sandonis, M. Alonso-Nieto, J. L. Vicario, S. Garcia, V. Hernando, C. Rodriguez, J. del Romero, and C. Lopez-Galindez. 2005. A subset of human immunodeficiency virus type 1 long-term non-progressors is characterized by the unique presence of ancestral sequences in the viral population. J. Gen. Virol. 86:355-364.
4. Brander, C. 2004. HLA and HlV: implications for HIV vaccine design. ASHI Q. 28:58-59.
5. Cao, K., J. Hollenbach, X. Shi, W. Shi, M. Chopek, and M. A. Fernandez-Vina. 2001. Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. Hum. Immunol. 62:1009-1030.
6. Costello, C., J. Tang, C. Rivers, E. Karita, J. Meizen-Derr, S. Allen, and R. A. Kaslow. 1999. HLA-B*5703 independently associated with slower HIV-1 disease progression in Rwandan women. AIDS 13:1990-1991.
7. Dorak, M. T., J. Tang, A. Penman-Aguilar, A. O. Westfall, I. Zulu, E. S. Lobashevsky, N. G. Kancheya, M. M. Schaen, S. A. Allen, and R. A. Kaslow. 2004. Transmission of HIV-1 and HLA-B allele-sharing within serodiscordant heterosexual Zambian couples. Lancet 363:2137-2139.
8. Doytchinova, I. A., P. Guan, and D. R. Flower. 2004. Identifiying human MHC supertypes using bioinformatic methods. J. Immunol. 172:4314-4323.
9. Fideli, U. S., S. A. Allen, R. Musonda, S. Trask, B. H. Hahn, H. Weiss, J. Mulenga, F. Kasolo, S. H. Vermund, and G. M. Aldrovandi. 2001. Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res. Hum. Retrovir. 17:901-910.
10. Frahm, N., S. Adams, P. Kiepiela, C. H. Linde, H. S. Hewitt, M. Lichterfeld, K. Sango, N. V. Brown, E. Pae, A. G. Wurcel, M. Altfeld, M. E. Feeney, T. M. Allen, T. Roach, M. A. St. John, E. S. Daar, E. Rosenberg, B. Korber, F. Marincola, B. D. Walker, P. J. Goulder, and C. Brander. 2005. HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-Lymphocyte epitopes and is associated with low human immunodeficiency virus load. J. Virol. 79:10218-10225.
11. Gao, X., A. Bashirova, A. K. Iversen, J. Phair, J. J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, M. Altfeld, S. J. O'Brien, and M. Carrington. 2005. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat. Med. 11:1290-1292.
12. Goulder, P. J. 2000. Rapid characterization of HIV clade C-specific cytotoxic T lymphocyte responses in infected African children and adults. Ann. N. Y. Acad. Sci. 918:330-345.
13. Haynes, B. F. 1996. HIV vaccines: where we are and where we are going. Lancet 348:933-937.
14. Kiepiela, P., A. J. Leslie, I. Honeyborne, D. Ramduth, C. Thobakgale, S. Chetty, P. Rathnavalu, C. Moore, K. J. Pfafferott, L. Hilton, P. Zimbwa, S. Moore, T. Allen, C. Brander, M. M. Addo, M. Altfeld, I. James, S. Mallal, M. Bunce, L. D. Barber, J. Szinger, C. Day, P. Klenerman, J. Mullins, B. Korber, H. M. Coovadia, B. D. Walker, and P. J. Goulder. 2004. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432:769-775.
15. Longmate, J., J. York, C. La Rosa, R. Krishnan, M. Zhang, D. Senitzer, and D. J. Diamond. 2001. Population coverage by HLA class-I restricted cytotoxic T-lymphocyte epitopes. Immunogenetics 52:165-173.
16. Lopez-Vazquez, A., A. Mina-Blanco, J. Martinez-Borra, P. D. Njobvu, B. Suarez-Alvarez, M. A. Blanco-Gelaz, S. Gonzalez, L. Rodrigo, and C. Lopez-Larrea. 2005. Interaction between KIR3DL1 and HLA-B*57 supertype alleles influences the progression of HIV-1 infection in a Zambian population. Hum. Immunol. 66:285-289.
17. Martin, M. P., X. Gao, J. H. Lee, G. W. Nelson, R. Detels, J. J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, J. Trowsdale, M. Wilson, S. J. O'Brien, and M. Carrington. 2002. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31:429-434.
18. McKenna, S. L., G. K. Muyinda, D. Roth, M. Mwali, N. Ng'andu, A. Myrick, C. Luo, F. H. Priddy, V. M. Hall, A. A. von Lieven, J. R. Sabatino, K. Mark, and S. A. Allen. 1997. Rapid HIV testing and counseling for voluntary testing centers in Africa. AIDS 11(Suppl. 1):S103-S110.
19. Novitsky, V., P. O. Flores-Villanueva, P. Chigwedere, S. Gaolekwe, H. Bussman, G. Sebetso, R. Marlink, E. J. Yunis, and M. Essex. 2001. Identification of most frequent HLA class I antigen specificities in Botswana: relevance for HIV vaccine design. Hum. Immunol. 62:146-156.
20. Novitsky, V., P. Gilbert, T. Peter, M. F. McLane, S. Gaolekwe, N. Rybak, I. Thior, T. Ndung'u, R. Marlink, T. H. Lee, and M. Essex. 2003. Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection. J. Virol. 77:882-890.
21. Novitsky, V., N. Rybak, M. F. McLane, P. Gilbert, P. Chigwedere, I. Klein, S. Gaolekwe, S. Y. Chang, T. Peter, I. Thior, T. Ndung'u, F. Vannberg, B. T. Foley, R. Marlink, T. H. Lee, and M. Essex. 2001. Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific Elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design. J. Virol. 75:9210-9228.
22. Reche, P. A., and E. L. Reinherz. 2004. Definition of MHC supertypes through clustering of MHC peptide binding repertoires. Artificial Immune Systems, ICARIS. Lect. Notes Comput. Sci. 3239:189-196.
23. Scherer, A., J. Frater, A. Oxenius, J. Agudelo, D. A. Price, H. F. Gunthard, M. Barnardo, L. Perrin, B. Hirschel, R. E. Phillips, and A. R. McLean. 2004. Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS. Proc. Natl. Acad. Sci. USA 101:12266-12270.
24. Sette, A., and J. Sidney. 1998. HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. Curr. Opin. Immunol. 10:478-482.
25. Sette, A., and J. Sidney. 1999. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50:201-212.
26. Stewart-Jones, G. B., G. Gillespie, I. M. Overton, R. Kaul, P. Roche, A. J. McMichael, S. Rowland-Jones, and E. Y. Jones. 2005. Structures of three HIV-1 HLA-B*5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression. J. Immunol. 175:2459-2468.
27. Tang, J., C. Costello, I. P. Keet, C. Rivers, S. Leblanc, E. Karita, S. Allen, and R. A. Kaslow. 1999. HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection. AIDS Res. Hum. Retrovir. 15:317-324.
28. Tang, J., S. Tang, E. Lobashevsky, A. D. Myracle, U. Fideli, G. Aldrovandi, S. Allen, R. Musonda, and R. A. Kaslow. 2002. Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1. J. Virol. 76:8276-8284.
29. Tang, J., S. Tang, E. Lobashevsky, I. Zulu, G. Aldrovandi, S. Allen, and R. A. Kaslow. 2004. HLA allele sharing and HIV type 1 viremia in seroconverting Zambians with known transmitting partners. AIDS Res. Hum. Retrovir. 20:19-25.
30. Tang, J., C. M. Wilson, S. Meleth, A. Myracle, E. Lobashevsky, M. J. Mulligan, S. D. Douglas, B. Korber, S. H. Vermund, and R. A. Kaslow. 2002. Host genetic profiles predict virological and immunological control of HIV-1 infection in adolescents. AIDS 16:2275-2284.
31. Trachtenberg, E., B. Korber, C. Sollars, T. B. Kepler, P. T. Hraber, E. Hayes, R. Funkhouser, M. Fugate, J. Theiler, Y. S. Hsu, K. Kunstman, S. Wu, J. Phair, H. Erlich, and S. Wolinsky. 2003. Advantage of rare HLA supertype in HIV disease progression. Nat. Med. 9:928-935.
32. Zeger, S. L., and K. Y. Liang. 1986. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121-130.